2024 FSP Annual Conference



Save the date for the FSP's 50th Annual Pathology Conference Updates and Practical Approaches in Pathology taking place on February 16-18, 2024 at Disney's Grand Floridian Resort in Orlando, FL. We hope to see you there!


Registration for this activity is closed.


Sylvia L. Asa, MD, PhD
University Hospitals Cleveland Medical Center and Case Western Reserve University  
Cleveland, OH
Topic: Thyroid/Neuroendocrine

Teri A. Longacre, MD
Richard Kempson Endowed Professor of Surgical Pathology
Director, Gastrointestinal Pathology
Director, Gynecologic Pathology
Stanford Medicine & Stanford Cancer Center
Stanford, CA
Topic: GYN 

Andrew E. Rosenberg, MD
Vice Chair Faculty Affairs; Co-Director of Anatomic Pathology; Director of Bone and Soft Tissue Pathology
Miller School of Medicine University of Miami
Miami, FL
Topic: Bone and Soft Tissue

William D. Travis, MD
Attending Thoracic Pathologist
Memorial Sloan Kettering Cancer Center
New York, NY
Topic: Lung/Pulmonary

Educational Symposium Faculty

Erika Harper, DO
Assistant Member – Breast Pathology
Moffitt Cancer Center
Tampa, FL

Atousa Ordobazari, MD
Assistant Member 
Moffitt Cancer Center
Tampa, FL

Humberto Trejo Bittar, MD
Associate Member/ Associate Professor
Moffitt Cancer Center
Tampa, FL

Aram Vosoughi, MD
Assistant Member
Moffitt Cancer Center
Tampa, FL

Case Presenters

Sibel Gultekin, MD
Jackson Memorial Hospital/ University of Miami
Miami, FL

Rasam Hajiannasab, MD
Oncologic surgical pathology fellow
Moffitt Cancer Center
Tampa, FL

Diego M. Montoya Cerrillo, MD
University of Miami / Jackson Memorial Hospital
Miami, FL

Sunaina Shrestha, MD
University of Florida
Gainesville, FL

Gul Emek Yuksek Wymer, MD
HCA Florida Westside Hospital
Plantation, FL


To view the presentation slides please log in to your account

Friday, February 16, 2024

8:00 am - 7:30 pm
Registration Open  


10:00 am - 11:30 am
Diagnostic pitfalls in organ-specific oncologic surgical pathology Educational Symposium (Hosted by Moffitt Cancer Center)
Erika Harper, DO, Atousa Ordobazari, MD, Humberto Trejo Bittar, MD, Aram Vosoughi, MD


12:00 pm - 12:45 pm
Non-CME Product Theater Lunch   


1:00 pm - 1:15 pm
Marilyn Bui, MD, PhD, FSP President


1:15 pm - 2:15 pm
Endometriosis-Associated Tumors: Differential Diagnosis
Teri A. Longacre, MD


2:15 pm - 3:15 pm
Endocervical Adenocarcinoma: HPV-Associated & HPV-Independent
Teri A. Longacre, MD


3:15 pm - 3:45 pm
Refreshment Break with Exhibitors and Poster Sessions  


3:45 pm - 4:45 pm
Ovarian Sex-Cord Stromal: Is it Normal/Physiologic or a Tumor? If Tumor, Which One? Microscopy Session
Teri A. Longacre, MD


4:45 pm - 5:30 pm
Microscopy Read Slides Session- Interesting or unusual cases in bone and soft tissue
Andrew E. Rosenberg, MD


5:30 pm - 6:30 pm
Roundtable Head/Neck Pathology discussion   


6:30 pm - 7:30 pm
Welcome Reception with Exhibitors and Poster Sessions  


Saturday, February 17, 2024

7:00 am - 4:30 pm
Registration Open   


7:00 am - 8:00 am
Continental Breakfast with Exhibitors and Poster Sessions   


7:55 am - 8:00 am
Morning Notes and Overview  


8:00 am - 9:00 am
Updates in Classification of Lung Cancer
William D. Travis, MD


9:00 am - 10:00 am
Classification of Idiopathic Interstitial Pneumonias
William D. Travis, MD


10:00 am - 10:45 am
Refreshment Break with Exhibitors and Poster Sessions  


10:45 am - 11:45 am
Challenging but instructive lung tumors Microscopy Session
William D. Travis, MD


12:00 pm - 12:45 pm
Non-CME Product Theater
Lunch served


1:00 pm - 1:30 pm
FSP Business Meeting   


1:30 pm - 1:50 pm
Recent, Ongoing, and Future Legal Matters Affecting Your Practice (non-CME)
Patrick Montoya


1:50 pm - 2:00 pm
An Update from the FMA (non-CME)
Ronald Giffler, MD


2:00 pm - 2:30 pm
The CAP: The Big Tent for Pathologists
Donald S. Karcher, MD, FCAP, President, College of American Pathologists


2:30 pm - 3:30 pm
Rare and Interesting Case Session  


3:30 pm - 4:30 pm
FSP Resident Jeopardy   


3:30 pm - 4:30 pm
Non-CME Product Theater  


4:30 pm - 5:30 pm
Fellowship Fair and Reception   


6:00 pm - 7:00 pm
FSP 50th Anniversary Celebration
Ticketed event


Sunday, February 18, 2024

7:00 am - 12:15 pm
Registration Open   


7:00 am - 8:00 am
Continental Breakfast with Exhibitors   


8:00 am - 8:15 am
Morning Notes and Overview   


8:15 am - 9:15 am
Update on the 5th Edition WHO Classification of Thyroid Tumors
Sylvia L. Asa, MD, PhD


9:15 am - 10:15 am
Neuroendocrine Neoplasia from Head to Toe
Sylvia L. Asa, MD, PhD


10:15 am - 11:00 am
Refreshment Break with Exhibitors  


11:00 am - 12:00 pm
A Potpourri of Endocrine Pathology Microscopy Session
Sylvia L. Asa, MD, PhD


12:00 pm - 12:15 pm
Closing Remarks   



The FSP 2024 Annual Pathology Conference will take place at Disney’s Grand Floridian Resort & Spa.


A train passing by a large white building with Disney's Grand Floridian Resort & Spa in the backgroundDescription automatically generated

Disney’s Grand Floridian Resort & Spa
4401 Floridian Way
Lake Buena Vista, Florida 32830

Disney's Grand Floridian Resort & Spa is SOLD OUT for our room block.

FSP has a discounted room rate at Disney's Coronado Springs Resort at $249 a night. Disney's Coronado Springs Resort is about a 10 minute drive from FSP's conference venue at the Grand Floridian. Self-parking is complimentary on both properties.

About Disney’s Grand Floridian Resort & Spa

Victorian elegance meets modern sophistication at this lavish Disney Resort hotel. Relax in the sumptuous lobby as the live orchestra plays ragtime, jazz, and popular Disney tunes. Unwind outdoors, indulge in a luxurious massage and watch evening fireworks light up the sky over Cinderella Castle. Just one stop to Magic Kingdom Park on the complimentary Resort Monorail, this timeless Victorian-style marvel evokes Palm Beach’s golden era.

Room Reservation Deadline:

The discounted room rate is available until January 25, 2024, or until the room block is full. Attendees must first register for the meeting and once registered, will receive a confirmation email with the link and special code to book a room.


Accreditation Information


Please join us at the FSP's 50th Annual Pathology Conference taking place on February 16-18, 2024 at Disney Grand Floridian Resort & Spa. Exhibitors will connect with over 250 pathologists during the conference as well as engage in over 15 hours of face to face time with attendees.
Other benefits include:

  • Pre and post attendee lists.
  • Benefit from listings on onsite signage, virtual exhibit hall and the FSP onsite guide.
  • Gain maximum exposure with prize giveaways and breaks scheduled in the exhibit hall.
  • Receive between 2-6 complimentary badges to access the exhibit hall dependent on sponsorship level chosen.

Please contact Paige Hay at exhibits@flpath.org if you have any questions or would like to discus sponsorship opportunities

Exhibitors registration has ended

View/Download Prospectus

Satellite Events


Special Events

Puppy Cuddle Break 

Date: Saturday, February 17

Time: 7:00 AM - 11:00 AM

There will be a “puppy cuddle break” at the FSP booth in the exhibit hall on Saturday from 7:00 am – 11:00 am where a local pet rescue will be bringing puppies for cuddles and even adoption for anyone who wants! Stop by the FSP booth to get some furry therapy that will guarantee to make you smile and melt away any of your meeting stress!

Resident Jeopardy

Date: Saturday, February 17

Time: 3:30 PM - 4:30 PM

For the first time ever, the Resident and Fellow Committee will be hosting Resident Jeopardy on Saturday, February 17 from 3:30 pm to 4:30 pm. There will be 5 pathology residency programs competing and the winning team will receive a trophy to take home with them. The competition is open to anyone to  watch so we will hope you will join in on the fun and cheer on your favorite team!

Fellowship Fair

Date: Saturday, February 17

Time: 4:30 PM - 5:30 PM

Residents and Fellows are invited to attend the FSP Fellowship Fair on Saturday, February 17 from 4:30-5:30 pm. The purpose of the fellowship fair is to showcase the various fellowship programs in Florida and to provide a unique opportunity for our residents in attendance to learn about the pathology fellowship programs available to them. The event is an excellent opportunity for both programs and residents to get to know each other. The following Programs will have representatives at the Fellowship Fair:

Broward County Medical Examiner
Moffitt Cancer Center (USF)
Mount Sinai Medical Center

University of Florida (Gainesville)
University of Miami 

50th Annual Pathology Conference Reception

Date: Saturday, February 17

Time: 6:00 PM - 7:00 PM

This is a very special year as we are celebrating FSP’s 50th conference anniversary! Join us on Saturday, February 17 in the evening for food, drinks, networking, and a few "magical" surprises. The reception will be held at Disney’s Grand Floridian Resort after the education sessions are completed for the day from 6:00pm – 7:00pm. This reception is free for FSP members. Non-members and guests can attend for only $25 charge.  Tickets will be given to attendees when you check in at the registration desk.

Please visit the FSP registration page to RSVP/pay for your ticket to the reception.

Thank you to Quest Diagnostics for sponsoring this event. 

Confirmed Exhibitors

Thank you to the following companies for their support of the FSP 2024 Annual Pathology Conference

At AbbVie, we strive to discover and develop medicines that deliver transformational improvements in cancer treatment by uniquely combining our deep knowledge in core areas of biology with cutting-edge technologies, and by working together with our partners – scientists, clinical experts, industry peers, advocates, and patients. We remain focused on delivering these transformative advances in treatment across some of the most debilitating and widespread cancers. We are also committed to exploring solutions to help patients obtain access to our cancer medicines. AbbVie's oncology portfolio now consists of marketed medicines and a pipeline containing multiple new molecules being evaluated worldwide in more than 300 clinical trials and more than 20 different tumor types. For more information, please visit http://www.abbvie.com/oncology.

APS Medical Billing is a premier billing firm that provides expert billing and practice management solutions to pathology and laboratory practices nationwide. APS’ clients range in size from a single-physician practice to large, multi-site academic departments, reference and independent labs. The scope of our billing services and proven strategies allow APS to effectively bill for professional, technical and global components of anatomic and clinical pathology services. Please visit our website at www.apsmedbill.com.


Agilent is a leader in life sciences, diagnostics and applied chemical markets. The company provides laboratories worldwide with instruments, services, consumables, applications, and expertise, enabling customers to gain the insights they seek. Agilent's expertise and trusted collaboration give them the highest confidence in our solutions. Agilent focuses its expertise on six key markets, where we help our customers achieve their goals including Food, Environmental and Forensics, Diagnostics, Pharmaceutical, Chemical and Energy, and Research. We provide trusted answers, together with our customers, through our integrated pathology solutions. Our portfolio includes a full range of world-class products, service and support that meet the individual needs of your lab and enables efficient, cost-effective and accurate diagnosis for cancer patients.

We are committed to providing doctors with the highest quality, clinicopathologic discussion possible. We recognize that in order to best serve the needs of our clinicians we must work together with them, not just as a lab, but as an extension of their practice. It is our goal to help equip doctors with the results they need to deliver the most effective patient care possible. As pathologists, we recognize that the longest period in a patient’s life is the timeframe between the day he/she has a biopsy, and the day the result arrives.

Our ambition is to push the boundaries of science to change the practice of medicine and transform the lives of cancer patients. We target the underlying biology of cancer in Immuno-Oncology, Tumor Drivers/Resistance, DNA Damage Response and Antibody Drug Conjugates. Utilizing precision medicine and biomarker-driven indications we look to dramatically improve five-year survival. Our focus on early disease stages and relapsed patients is to 1) identify and treat patients earlier with curative intent; and 2) support relapsed and refractory patients by tackling primary or acquired resistance.


Biocartis is an innovative molecular diagnostics company committed to revolutionize molecular testing with its unique proprietary IdyllaTM platform. We provide next generation diagnostic solutions, aimed at improving clinical practice for the benefit of patients, clinicians, payers and the healthcare industry, with a focus in oncology which represents the fastest growing segment of the MDx market worldwide. Today, Biocartis offers tests supporting melanoma, colorectal and lung cancer, as well as for sepsis.

We are working to advance a deep pipeline of precision therapies, designed to allow patients to live longer, healthier lives. Our approach combines our leading expertise in protein kinases with sound execution and an intense focus on discovery. We maintain a diverse and growing portfolio of research programs, moving multiple investigational medicines through clinical development for patients with a broad range of genomically defined cancers and rare diseases.

Bristol Myers Squibb is a global biopharmaceutical company whose mission is to discover, develop and deliver innovative medicines that help patients prevail over serious diseases. 

Caris Life Sciences® (Caris) is the leading next-generation AI TechBio company and precision medicine pioneer actively developing and delivering innovative solutions to revolutionize healthcare and improve the human condition. Through comprehensive molecular profiling (DNA, RNA and proteins) and the application of AI and machine learning algorithms, Caris has created the large-scale, clinico-genomic database and computing capability needed to analyze and unravel the molecular complexity of disease. This provides an unmatched platform to deliver the next-generation of precision medicine tools for early detection, diagnosis, monitoring, therapy selection and drug development. To learn more, please visit www.CarisLifeSciences.com.


Cleveland Clinic Laboratories is a full-service, national reference laboratory dedicated to providing world-class care. Our laboratories offer high-quality, clinically impactful pathology and laboratory diagnostics services combined with readily available consultation from experienced pathologists and laboratory scientists.


Coronis Health is a healthcare revenue cycle management company leading the industry with a data-driven, proprietary experience coined The Coronis Way. By leveraging industry-leading technology, strategic partnerships, and high-touch relationships, Coronis Health allows healthcare providers and facilities to focus on maintaining exceptional patient care with the best possible financial results.


Daiichi Sankyo, Inc., the U.S. subsidiary of Daiichi Sankyo Co., Ltd., is headquartered in Basking Ridge, New Jersey, and is focused on the development and delivery of oncology and specialty medicines. Daiichi Sankyo, Inc. medicines approved in the U.S. include therapies for metastatic breast, lung and gastric cancer, tenosynovial giant cell tumor and iron deficiency anemia.


Lilly aims to create medicines that make life better for all those affected by cancer around the world.  Bringing together the focus and spirit of a biotech with the scale, resources, and heritage of Lilly, our team is focused on rapidly delivering impactful new medicines for people with cancer. Our approach centers on creating oncology medicines that unequivocally show early signs of clinical activity and will matter to patients.


General Data Healthcare, a division of General Data Company, Inc. and a global leader in identification and tracking technologies for healthcare, today announced the launch of the newest addition to it's LaserTrack portfolio of cassette printers for histology and anatomical pathology – the LaserTrack FLEX.



Considered the founder of the industry, Genentech, now a member of the Roche Group, has been delivering on the promise of biotechnology for more than 40 years. Genentech is a biotechnology company dedicated to pursuing groundbreaking science to discover and develop medicines for people with serious and life-threatening diseases. Our transformational discoveries include the first targeted antibody for cancer and the first medicine for primary progressive multiple sclerosis.


Gestalt Description: Gestalt transforms pathology through an intelligent, configurable, and vendor-neutral digital workflow that provides true interoperability enabling pathologists to diagnose diseases faster and more efficiently. Our PathFlow® solution is a cloud-based digital pathology enterprise platform that can easily be customized based on your specific preferences. This platform consists of professional, education, and research modules for ease of mixing and matching the digital needs of your facility in a single solution, freeing pathologists from tedious, repetitive, and manual tasks allowing them to focus on their expertise, providing their invaluable experience where it matters most.


Passionate about advancing cancer diagnostics, GoPath Diagnostics is a leading full-service laboratory specializing in cancer genetics, molecular, and anatomic pathology. Our cutting-edge technologies, global partnerships, and innovative solutions—GeneticsNow, OncoTarget, and OncoTracking—empower healthcare decisions. Proudly based in Buffalo Grove, IL, our comprehensive services encompass IHC, FISH, PCR testing, flow cytometry, cytogenetics, micro-array, and NGS.


Hamamatsu Corporation is the North American subsidiary of Hamamatsu Photonics K.K. (Japan). We manufacture detectors, light sources, cameras, and systems including the NanoZoomer instruments for whole slide scanning in both brightfield and fluorescence applications. The NanoZoomer converts glass slides into digital images quickly and accurately, making it perfect for viewing and analyzing the slides. Our instruments deliver reliable scanning and image quality you’ve come to expect from Hamamatsu.


With over 75 years of combined experience, Hankins Consulting understands the complexities of running the day to day in Pathology laboratories. We cover a range of services, including complete turnkey lab build-out solutions, lab management consulting, staff acquisitions, licensing, compliance services, laboratory operational efficiency consulting, specimen transport, supply fulfillment, kitting services and pathology billing/revenue cycle services. Hankins Consulting Group’s goal is to provide our clients with the solutions they require to maximize profitability, patient care, and, ultimately, their work/life balance.


HCA Healthcare is dedicated to giving people a healthier tomorrow. As one of the nation's leading providers of healthcare services, HCA Healthcare is comprised of 182 hospitals and 2,300+ sites of care in 20 states and the United Kingdom. In addition to hospitals, sites of care include surgery centers, freestanding ERs, urgent care centers, diagnostic and imaging centers, walk-in clinics and physician clinics. Many things set HCA Healthcare apart from other healthcare organizations; however, at our core, our greatest strength is our people. Every day, more than 290,000 colleagues go to work with a collective focus: our patients. Our focus positively impacts the care experience at the bedside and beyond.


Since 2016, Ibex has led the way in AI-powered diagnostics for pathology. We set out to transform pathology by ensuring that every patient can receive an accurate, timely and personalized cancer diagnosis. Today, we are the most widely-deployed artificial intelligence platform in pathology. Developed by pathologists for pathologists, our solutions serve the world’s leading physicians, healthcare organizations and diagnostic providers. Every day, we have the privilege of touching the lives of patients worldwide. We raise physician confidence, streamline diagnostic workflows, help clinicians provide more personalized diagnosis and, most importantly, enable better clinical outcomes.


Targeting a better life for people with cancer is why we get up in the morning. It’s not enough to disrupt the progress of someone’s cancer; we want to keep cancer from disrupting someone’s life. That’s why everything we do is about developing the most precise, targeted cancer therapies. We believe this is the best way to get people back to their lives – back to living today, tomorrow, and beyond. For us, targeting a better now is the only thing that matters.

At Innovative Science Press, we are dedicated to the advancment of pathologists by producing and disseminating educational textbooks. We believe that all pathologists deserve access to quality and affordable medical training in order to help their patients. For this reason, our books are written by some of the most prominent in the field and are reasonably priced. We provide steep discounts to residents and fellows to make our products more affordable and donate frequently to the under-served countries.


Molecular diagnostic testing for indeterminate thyroid nodules utilizing multi platform testing. ThyGeNEXT is an oncogenic mutation panel that helps identify malignant thyroid nodules and ThyraMIR is a proprietary microRNA gene expression assay that helps to clarify the risk of cancer in thyroid nodules.


Kedrion SpA (“Kedrion”) is an international company that collects and fractionates blood plasma to produce and distribute plasma-derived therapeutic products for use in treating and preventing serious diseases, disorders and conditions such as hemophilia, Primary Immune Deficiency and Rh sensitization which can lead to hemolytic disease of the fetus and newborn. Kedrion Biopharma Inc. (“Kedrion Biopharma”), the US subsidiary of Kedrion, is headquartered in Fort Lee, New Jersey. Kedrion Biopharma launched US operations in 2011, but the company’s international roots stretch back several decades in the production of blood and plasma-derived products. It places a high value not only on the welfare of those who benefit from its products but also on the people and communities it serves.


Our comprehensive, specialized diagnostic testing menu keeps you informed throughout the continuum of care—from screening, diagnosis and prognosis to treatment options and response. Our global oncology-specific expertise helps advance cancer diagnostics, drugs and devices through the full drug development continuum with speed and efficiency. We provide powerful data and advanced technologies to inform preclinical decisions and oncology model selection; design, manage and recruit for clinical trials; leverage appropriate decentralized techniques; generate ongoing real-world evidence; and perform long-term follow-up studies to support the ongoing development of your product. 


For more than four decades, MagMutual has been a leading provider of medical professional liability insurance. Today, we deliver comprehensive insurance coverage, along with customized advice, exceptional claims support and consistent financial benefits, to more than 40,000 healthcare providers and organizations nationwide.


Mayo Clinic Laboratories strives to ensure patients around the world have access to the most advanced diagnostic testing. Working with hospitals and health care providers worldwide, we deliver the latest in diagnostic testing to provide answers and improve outcomes for their patients. With the world’s most sophisticated test catalog, our testing incorporates scientific discoveries, cutting-edge technologies, and unparalleled expertise to solve the most rare and complicated cases. 

MedReceivables Advisor, LLC is a full service outsourcing medical billing company for the hospital-based physician. Our company provides complete accounts receivable management services for hospital-based physicians.



For more than 130 years, we have brought hope to humanity through the development of important medicines and vaccines. We aspire to be the premier research-intensive biopharmaceutical company in the world — and today, we are at the forefront of research to deliver innovative health solutions that advance the prevention and treatment of diseases in people and animals. We foster a diverse and inclusive global workforce and operate responsibly every day to enable a safe, sustainable and healthy future for all people and communities.


MLabs is a full-service reference laboratory, with more than 35 years’ experience providing state-of-the-science tools and expertise to help clinicians and patients choose the right clinical path. MLabs is part of Michigan Medicine – one of the largest hospital systems in the world, and one of the best – ranked #11 in the nation and #1 in the state by U.S. News and World Report.MLabs’ hybrid model combines the scientific rigor and proactive infrastructure investment of a leading academic research institution with the efficiency, flexibility and responsiveness of a private reference lab.MLabs connects pathologists, clinicians, health systems and commercial laboratories with the next-generation testing modalities and consultative support needed to meet the challenges of personalized, precision medicine.


Milestone Medical's mission is to reduce patient anxiety by standardizing and expediting the pre-analytical steps of the histopathology lab and the operating room specimen collection and transportation. In doing so, our goal is to enable superior quality, same-day diagnoses.  Milestone is proud to offer innovative solutions in 6 different fields:  Tissue Processing, Specimen Handling, Frozen sections, Cytology, Macro-Digital and Reagents. 

At Moffitt, ours is an unrelenting mission to save more lives. That’s why we are accelerating the science with greater urgency than ever before. We are Florida’s top choice of the best outcomes. For an accurate diagnosis and individualized treatment plan from the start, choose Moffitt first. 


MSN's Pathology Solutions Team has over 20 years of pathology billing experience working with hospital-based practices and outreach facilities.  We balance the skills and understanding of our expert billing staff with excellent technology,a combination resulting in diligent claims follow-up and collection activity for our pathology clients.  MSN is passionate about client service, and we build strong partnerships with the pathology groups we serve.  We are dedicated to becoming one of the leading pathology billing companies in the country.


At Myriad, social responsibility plays an important role in our approach to discovering and delivering valuable, transformative diagnostic tests across all major diseases to improve patients’ lives.


NeoGenomics is a Florida-based premier cancer diagnostics and pharma services company serving oncologists, pathologists, pharmaceutical companies, academic centers, and others with innovative diagnostic, prognostic, and predictive testing. Our vision embodies uncompromising quality, exceptional service, and innovative solutions. We have a network of CAP-accredited, CLIA-certified facilities in the US and offer global capabilities with laboratories in Switzerland and Singapore. 


The Nikon Microscope Solutions unit is a part of the Nikon Healthcare Business Division of the Nikon Group of companies. The Microscope Solutions unit is focused on serving customers in research, biotech/pharma, the clinical laboratory, and education with industry leading microscope-based imaging solutions.


Novartis is an innovative medicines company. Every day, we work to reimagine medicine to improve and extend people’s lives so that patients, healthcare professionals and societies are empowered in the face of serious disease. Our medicines reach more than 250 million people worldwide.

Paige is using the power of AI to drive a new era of cancer discovery and treatment. To improve the lives of patients with cancer, Paige has created a cloud-based platform that transforms pathologists’ workflow and increases diagnostic confidence as well as productivity, all on a global scale. Paige is the first company to receive FDA approval for a clinical AI application in digital pathology. The same Paige technology empowers pharmaceutical companies to more effectively evaluate treatment options for patients and design new biomarkers for drug development so that every patient gets precise treatment options.


As an industry leader, PathGroup provides comprehensive anatomic, clinical and molecular pathology services. We operate 24 hours a day, 7 days a week to deliver fast and accurate results, with a responsiveness that is unmatched in the industry. PathGroup is privately held and physician centered, designed to work seamlessly with medical practices and provide direct consultation when needed. Our approach is keenly focused on driving better patient outcomes through high-quality, high-service diagnostics from a single point of contact.



PIMS Inc. was incorporated in 1998 and has evolved into a full-service Medical Billing and Practice Management Services company. PIMS provides comprehensive billing and consulting services for providers of all sizes. In addition, PIMS offers an innovative and robust laboratory information system designed specifically for the anatomic pathology practice in mind.Headquartered in our state-of-the-art 23,000 square-foot facility in Tampa, Florida, PIMS is led by a senior management team with many years of diversified medical billing and healthcare revenue cycle management experience. With 100+ highly trained employees, we have you covered.


Private Autopsy Associates Services provides answers to families, legal firms, physicians, funeral homes, hospitals, attorneys and insurance companies. A private autopsy can reveal critical and conclusive evidence of the cause of death – for the peace of mind of the relatives. For a free consultation about private autopsies please send an email to autopsies@autopsyflorida.com or call (813) 895-5895.

As the world’s leading provider of diagnostic information services, Quest Diagnostics and all our employees are committed to The Quest Way, sharing our purpose, strategy, and culture—through working every day to uncover important insights about your health. We’re dedicated to providing actionable results that empower you with the information you need to make your healthcare decisions count through:

  • Discovering new ways to screen for, prevent, diagnose, and monitor disease
  • Making it faster and easier for consumers, patients, doctors, and hospitals to access lab tests and data when they need it
  • Ensuring patients obtain the services and care they need when they need it
  • Solving health inequities and working collaboratively to make communities healthier

Throughout our 125-year history, Roche has grown into one of the world’s largest biotech companies, as well as a leading provider of in-vitro diagnostics and a global supplier of transformative innovative solutions across major disease areas. Our commitment to our people, partners, stakeholders and, most importantly, our patients remains as strong as it was on the first day of our journey.


Seagen is a global biotechnology company that develops and commercializes transformative cancer therapies. We’re driven by a singular mission—to make a difference for people impacted by cancer. As an industry leader in antibody–drug conjugate (ADC) technology, we pioneered the science of harnessing antibodies designed to deliver cell-killing agents to cancer cells. Three of our four approved medicines are built on this technology. We also focus our research efforts on novel targeted small molecule therapies. In addition, we are leveraging our expertise in empowered antibodies to build a portfolio of proprietary immuno-oncology agents.

SpringWorks Therapeutics is a clinical-stage biopharmaceutical company that applies a precision medicine approach to acquiring, developing and commercializing life-changing medicines. We do it to help patients suffering from devastating cancers live longer, better lives. How? We scrutinize promising molecules from every angle to unlock their full potential. We forge collaborations with industry and academic innovators to multiply the opportunities for success. And we build our company with exceptional people who press beyond “good enough” to make a profound impact. In a word, we are tenacious. Are you with us?


By listening to our customers, we have developed innovative solutions protecting their investment. With proven integrity, we build trust and provide meaningful value. This is at the very core of who we are as an organization.


ThyroSeq® Genomic Classifier (GC) test utilizes next-generation sequencing to analyze DNA and RNA of 112 thyroid-related genes for four main classes of molecular alterations, including mutations, gene fusions, copy number alterations, and gene expression alterations. The results are processed by a unique Genomic Classifier (GC) and reported as Positive or Negative1.


University of Florida Health Pathology Laboratories provides surgical pathology and diagnostic laboratory services for the Southeast United States. Headquartered in Gainesville, Florida, UF Health Pathology Laboratories has offered pathology services, testing, pathology second opinion services and autopsy services for more than 20 years. We serve all major markets across the state of Florida, including Jacksonville, Orlando and Tampa.


The University of Miami Health System delivers leading-edge patient care by the region's best doctors, powered by the groundbreaking research and medical education of the University of Miami Leonard M. Miller School of Medicine. As South Florida's only university system, UHealth is a vital component of the community. UHealth combines patient care, research, and education to create a front-line approach to health care. Within the UHealth system, patients can participate in clinical trials and benefit from the latest developments that are fast-tracked from the laboratory to the bedside.


Veracyte is a global diagnostics company that empowers clinicians with the high-value insights they need to guide and assure patients at pivotal moments in the race to diagnose and treat cancer. We collaborate closely with physicians and researchers to identify unmet needs that stand in the way of better care. And then, we find the answers. Our high-performing tests enable clinicians to make more confident diagnostic, prognostic and treatment decisions for challenging diseases. These include thyroid, prostate, breast, bladder and lung cancers, as well as interstitial lung diseases. We help patients avoid unnecessary procedures and speed time to diagnosis and appropriate treatment. Our tests are available in the US through our central laboratories. We are also making our tests accessible to patients worldwide through other laboratories that can perform them locally.


Coming soon

The Florida Society of Pathologists (FSP) Poster Review Committee invites the submission of posters for inclusion in the Poster Hall during the FSP’s 50th Annual Pathology Conference taking place on February 16-18, 2024 at Disney’s Grand Floridian Resort in Orlando, Florida.  

The purpose of the FSP Poster Hall is to stimulate research, provide a venue to share innovative and effective educational programs, showcase unique research projects, and to encourage networking among pathologists.

All pathologists are invited to submit case-based posters or research-based posters for inclusion in the Poster Hall. Residents and fellows are eligible to compete in the FSP Poster Competition for prizes.

Back by popular demand, residents and fellows who are enrolled in a full-time approved training program in pathology or sub-specialty of pathology in the state of Florida are invited to submit and be eligible to participate in the FSP Poster Competition.

The poster author must register for the conference and pay a poster fee of $50 (included on the registration form). All e-posters must be submitted online once the submission portal opens. If your poster is not selected for display in the poster hall, FSP will provide a refund of this fee. Please add @flpath.org to your email "safe senders" or whitelist to ensure you receive important notifications from FSP.


Poster Submission Deadline
Monday, January 15, 2024
5:00 pm EST


Poster Submission Instructions
Please read through the submission instructions below before preparing your poster:

  1. Register for the Conference and pay the meeting registration and $50 poster fee.If you wish to submit more than 1 poster, you can indicate this on the meeting registration form.
  2. Submit your e-poster on this website through the online submission portal.


Please note, within the submission portal, you will be able choose and download a PowerPoint slide template. To download the templates to create your e-poster, click on the links below:

General Information and Policies:

  • Lead authors on all submissions are required to register for the conference and pay the applicable registration and poster fee.
  • Residents, fellows and students participating in the Poster Competition are required to present their poster in the Poster Hall on either Friday, February 16 or Saturday, February 17. All other pathologists submitting posters are not required to present their poster but are encouraged to be participate during poster viewing hours to answer questions from conference attendees.
  • Lead authors on all submissions are required to pay a $50 submission fee for each poster. Multiple posters may be submitted.
  • It is the responsibility of the submitter to ensure that his/her poster is submitted correctly.
  • Full disclosure of all authors must be provided by the time of submission. Any failure to fully comply with this requirement may result in the poster being withdrawn.
  • If judges deem that a poster must be edited or updated to be eligible for presentation, lead authors will be contacted by email.


Content Guidelines
Poster entries can only be accepted electronically and must adhere to the following guidelines:

  • Posters must have one central theme, include essential data and test, and be visually appealing.
  • Posters must be proofread carefully to avoid errors before submission.
  • Posters must contain generic drug names only.
  • Posters must be submitted in clear English with accurate grammar and spelling of quality suitable for publication.
  • Lead and secondary authors must disclose all financial relationships.
  • Any funding support for the research must be disclosed.
  • Encore research is not eligible for submission.
  • A maximum of 4 references are allowed.
  • Posters must not contain hyperlinks, videos, GIF files, and must be one slide only.


You will be asked for the following:

  • Short poster title (40-character title for use on onsite signage)
  • Author name(s)
  • Financial disclosures
  • Disclosure of funding support
  • Topic
  • Payment of registration and submission fee


The online poster submission does not allow you to save and return to resume later. Therefore, before starting your submission, have all materials and information ready. After the poster is submitted, you will receive an automated email to confirm your submission. If you do not receive the email within 24 hours, please contact the FSP office at posters@flpath.org or call 904-309-6261.


Poster Topics
The poster must relate to an appropriate topic in the field of pathology. Poster authors will be required to indicate which topic BEST matches the content of their poster. Topics are:

  • Blood Banking/Transfusion Medicine
  • Chemical Pathology
  • Clinical Informatics
  • Cytopathology
  • Dermatopathology
  • Forensic Pathology
  • Hematopathology
  • Medical Microbiology
  • Molecular Genetic Pathology
  • Neuropathology
  • Pediatric Pathology
  • Selective Pathology
  • Case Study
  • Other


Poster Competition Eligibility
Authors must be a resident or fellow enrolled in a full-time approved training program in pathology or sub-specialty of pathology in the state of Florida to be eligible to participate in the FSP Poster Competition.


Poster Competition Presentation Process and Awards
Posters submitted for the Poster Competition by residents and fellows will be pre-judged and selected by FSP judges based on quality, innovation, approach/design, and visuals. Posters will be judged twice and are subject to an additional preliminary review to determine eligibility. If judges deem that changes need to be made for posters to be eligible for presentation, lead authors will be contacted by email. The first judging will be done before the conference, and it will be a blind review. The second judging will be conducted during the poster presentation live at the conference in the FSP Poster Hall. The scores from both judging sessions will be combined to determine the winners. The first-place winner will receive $500, the second-place winner will receive $250, and the third-place winner will receive $150. To be considered for the competition, you must you must be a resident or fellow and you must submit your poster by the submission deadline. 

Onsite judging times will be assigned for residents and fellows that are participating in the Poster Competition, and authors will be notified of their presentation time. Presentation times will occur on Friday, February 17 and Saturday, February 18 so please make plans to be available on both days. All lead poster authors are required to register for the conference taking place on February 17-19, 2023 at Disney's Grand Floridian Resort in Orlando to present their poster to judges.*

Winners of the Poster Competition will be announced, and prizes will be awarded on Saturday, February 18.


The FSP will not be responsible for submissions not received via the website or for submission errors caused by Internet service outages, hardware or software delays, power outages, or unforeseen events. Faxed, emailed or mailed hard-copy posters or posters sent on a CD/disc WILL NOT be accepted. If you have questions, please contact the FSP office at posters@flpath.org or call 904-309-6261.


*Expenses related to registration, airfare, lodging, and social events/guest fees are the responsibility of the presenter.

Poster Submission Portal

Networking Events




Resident Jeopardy


Join us for FSP Resident Jeopardy on Saturday, February 17 from 3:30-4:30 pm in conjunction with the FSP Annual Pathology Conference at Disney’s Grand Floridian.

The goal of the Resident Jeopardy is to:

  • Provide an event where residents can interact;
  • Gain "bragging rights" for the year by taking the FSP Jeopardy Championship trophy home with your team;
  • But most of all, have FUN!

The FSP invites all pathology residency programs in the state of Florida to submit a team for the Resident Jeopardy competition. Each team can have up to 4 members and we would like to encourage residents from all levels of the training program to be represented on the team. The FSP will award the winning residency program team a “traveling” trophy at the conclusion of the game to keep at your program for the year until the next FSP annual meeting. Teams are encouraged to show their enthusiasm with a team name, team logo, matching t-shirts, hats, etc.  The FSP hopes to make this a yearly event and therefore, bragging rights will be challenged each year! We can’t wait to see you there!

To sign up please submit the form below to enroll your team.


Register Here!

Confirmed Sponsors


Rare and Interesting Case Competition


Pathology is hard! Every day, we are faced with challenging cases that require us to open books, read new articles, consult our friends and colleagues, and sometimes consult the experts. Join us on Saturday, February 17 from 2:30 to 3:30 to highlight the top 5 cases submitted. Each case will be presented, and attendees can view the slides ahead of the meeting.

The Florida Society of Pathologists is excited to announce that we will be using PathPresenter’s digital pathology software to host our "Rare and Interesting Cases" session this year. All attendees will have access to the digital pathology platform to view and assess the 5 cases online ahead of the meeting, as well as for review during the in-person session.

Attendees will also have the opportunity to vote on their favorite case at the end of the session on the mobile app and the top case will win a prize!

Cases Include:

  • Case 1: 69M Paraspinal mass- Rasam Hajiannasab, MD
  • Case 2: 69F lymph node- Gul Emek Yuksek Wymer, MD
  • Case 3: 24F foot mass- Diego M. Montoya Cerrillo, MD
  • Case 4: 56M leg mass- Sibel Gultekin, MD
  • Case 5: 76M lymph node- Sunaina Shrestha, MD